Norwegian version
Kristine Hole

Kristine Hole

Research projects

Scientific publications

Larsen, Rønnaug Eline; Hole, Kristine ; Selle, Maria; Landmark, Cecilie Johannessen ; Krogstad, Tonje ; Holm, Lene Berge (2024). Access to a tailored mobile application enhances medication adherence among young users of antidepressants. 10 p. Frontiers in Pharmacology. Vol. 15.
https://doi.org/10.3389/fphar.2024.1379700

Faraj, Pari; Haslemo, Tore ; Tran, Jenny Phung; Stingl, Julia; Molden, Espen; Hole, Kristine (2024). Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population. British Journal of Clinical Pharmacology.
https://doi.org/10.1111/bcp.16156

Hole, Kristine ; Lorentsen, Silje K; Nordby, Karoline L; Sørum, Ida TG; Molden, Espen; Haslemo, Tore (2024). Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets. European Journal of Clinical Pharmacology.
https://doi.org/10.1007/s00228-024-03655-z

Tveit, Kristine; Hermann, Monica; Nilsen, Roy Miodini; Wallerstedt, Susanna M.; Rongve, Arvid; Molden, Espen; Hole, Kristine (2024). Age of onset for increased dose-adjusted serum concentrations of antidepressants and association with sex and genotype: An observational study of 34,777 individuals. European Journal of Clinical Pharmacology. Vol. 80.
https://doi.org/10.1007/s00228-023-03611-3

Hole, Kristine ; Gangsø, Sofie; Jensstuen, Åse Tonette; Ormøy, Hanne Holte; Paulsen, Maren; Molden, Espen; Haslemo, Tore (2023). Effect of CYP2D6 genotype on duloxetine serum concentration. Basic & Clinical Pharmacology & Toxicology. Vol. 134.
https://doi.org/10.1111/bcpt.13954

Hole, Kristine ; Haslemo, Tore ; Molden, Espen (2023). Impact of CYP2D6 Genotype on Paroxetine Serum Concentration. 5 p. Therapeutic Drug Monitoring. Vol. 45.
https://doi.org/10.1097/FTD.0000000000001096

Faraj, Pari; Størset, Elisabet; Hole, Kristine ; Smith, Godfrey L; Molden, Espen; Dietrichs, Erik Sveberg (2023). Pro-arrhythmic effect of escitalopram and citalopram at serum concentrations commonly observed in older patients – a study based on a cohort of 19,742 patients. 10 p. EBioMedicine. Vol. 95.
https://doi.org/10.1016/j.ebiom.2023.104779

Faraj, Pari; Hermansen, Astrid; Molden, Espen; Hole, Kristine (2022). Identification of Escitalopram Metabolic Ratios as Potential Biomarkers for Predicting CYP2C19 Poor Metabolizers. 8 p. Therapeutic Drug Monitoring. Vol. 44.
https://doi.org/10.1097/FTD.0000000000000991

Kvitne, Kine Eide; Hole, Kristine ; Krogstad, Veronica; Wollmann, Birgit Malene Tovik; Wegler, Christine; Johnson, Line Kristin; Hertel, Jens Kristoffer; Artursson, Per; Karlsson, Cecilia; Andersson, Shalini; Andersson, Tommy B.; Sandbu, Rune; Hjelmesæth, Jøran Sture; Skovlund, Eva; Christensen, Hege; Jansson-Löfmark, Rasmus; Åsberg, Anders; Molden, Espen; Robertsen, Ida (2022). Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range. 10 p. European Journal of Clinical Pharmacology. Vol. 78.
https://doi.org/10.1007/s00228-022-03336-9

Kvitne, Kine Eide; Robertsen, Ida; Skovlund, Eva; Christensen, Hege Staaland; Krogstad, Veronica; Wegler, Christine; Angeles, Philip Carlo Soriano; Wollmann, Birgit Malene Tovik; Hole, Kristine ; Johnson, Line Kristin; Sandbu, Rune; Artursson, Per; Karlsson, Cecilia; Andersson, Shalini; Andersson, Tommy B.; Hjelmesæth, Jøran; Jansson-Löfmark, Rasmus; Åsberg, Anders (2021). Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity – a non-randomized three-armed controlled trial. 13 p. Clinical and Translational Science (CTS).
https://doi.org/10.1111/cts.13142





These publications are obtained from Cristin. The list may be incomplete